PALO ALTO, Calif. - Scilex Holding Company (NASDAQ:SCLX), a $77.5 million market cap company known for its focus on non-opioid pain management products, reported that the U.S. Food and Drug ...
Introduction An organ transplant is a surgical procedure replacing a damaged organ with a healthy one. Diagnostics for organ transplants are cl ...
scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results
We expect a mid-year submission of the sNDA ... to us in an amount sufficient to enable us to make interest or principal payments on our indebtedness when due; clinical and preclinical development ...
This preface begins with a consideration of the common political heritage, in Trotskyism, of the editor and creator of Fathom ...
Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral ... is currently approved in the United States for patients with advanced ...
The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.
Merck (MRK) announced the U.S. FDA has accepted for priority review a supplemental new drug application seeking approval of Welireg, Merck’s ...
Coordination, yes; subordination, no, Sheinbaum wrote on X. Sheinbaum proposed to US President Donald Trump to establish a working group which would include their “best public health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results